Damned If You Do, Damned If You Don't
Open Access
- 1 October 2010
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of the American Society of Nephrology
- Vol. 5 (10), 1723-1726
- https://doi.org/10.2215/cjn.03700410
Abstract
Sodium polystyrene sulfonate (SPS) potassium binding resins increase colonic potassium excretion and are approved by the U.S. Food and Drug Administration (FDA) for the treatment of hyperkalemia. In 2009, the FDA recommended that sorbitol, a cathartic often given with SPS to prevent obstipation, not be added to SPS powder because of associated colonic necrosis. A premixed oral suspension of SPS in 33% sorbitol was not included in this warning. SPS resins increase stool potassium excretion in normokalemic subjects, but proportionately more potassium is excreted due to cathartics when the two are combined. In hyperkalemic patients, oral SPS mixed in water significantly decreases serum potassium within 24 hours. SPS/sorbitol-associated colonic necrosis is most commonly seen in patients who have received enemas in the setting of recent abdominal surgery, bowel injury, or intestinal dysfunction. It is a rare event, on the order of 0.2 to 0.3%, almost exclusively present in patients at risk. The agent most likely associated with colonic necrosis is 70% sorbitol, and animal data support that etiology. There is very little data to suggest that oral SPS given with 33% sorbitol (in the premixed form) or SPS powder in water orally or as an enema causes colonic necrosis. SPS ion-exchange resins are the only agents, other than dialysis and diuretics, available to increase potassium excretion in hyperkalemia, and when used appropriately, they appear to be clinically effective and reasonably safe.This publication has 16 references indexed in Scilit:
- Ion-Exchange Resins for the Treatment of HyperkalemiaJournal of the American Society of Nephrology, 2010
- The Frequency of Hyperkalemia and Its Significance in Chronic Kidney DiseaseArchives of Internal Medicine, 2009
- Intestinal Necrosis due to Sodium Polystyrene Sulfonate (Kayexalate) in SorbitolSouthern Medical Journal, 2009
- Emergency Management and Commonly Encountered Outpatient Scenarios in Patients With HyperkalemiaMayo Clinic Proceedings, 2007
- Emergency Management and Commonly Encountered Outpatient Scenarios in Patients With HyperkalemiaMayo Clinic Proceedings, 2007
- Kidney Patient Care in DisastersClinical Journal of the American Society of Nephrology, 2007
- Hyperkalemia: A ReviewJournal of Intensive Care Medicine, 2005
- Effect of three laxatives and a cation exchange resin on fecal sodium and potassium excretionGastroenterology, 1995
- Hyperkalaemia in patients in hospital.BMJ, 1983
- PROPHYLACTIC HEMODIALYSIS IN THE TREATMENT OF ACUTE RENAL FAILUREAnnals of Internal Medicine, 1960